Connect with us

News

Google’s New AI Technology May Revolutionize Cancer Treatment

The AI model, called AlphaProteo, can design targeted protein binders, promising breakthroughs in cancer treatments and diseases like diabetes.

Published

on

google's new ai technology may revolutionize cancer treatment
Google DeepMind

Proteins are integral to many biological processes within the human body. They play a crucial role in our immune system, helping us to fend off diseases and maintain overall health.

Until now, developing protein molecules for medical purposes has been a time-consuming, expensive, and complex process. However, advancements in artificial intelligence have significantly improved the process, making it more efficient and accessible.

Recently, Google DeepMind researchers introduced a cutting-edge AI-powered model that can create protein binders targeting specific proteins. The groundbreaking development allows scientists to design custom protein molecules that specifically target only cancerous cells while minimizing harm to healthy ones. Hopefully, this will lead to more effective and less harmful treatments for cancer patients.

The newly developed AI model, known as AlphaProteo, also promises to be a game-changer in the diagnosis and treatment of various diseases, including autoimmune disorders like rheumatoid arthritis, and chronic illnesses such as diabetes.

This isn’t Google DeepMind’s first foray into using AI for protein research. In 2021, the company launched AlphaFold, another AI-powered system aimed at predicting the structure of proteins. AlphaProteo builds upon this foundation, further advancing AI’s role in medical research.

Also Read: Tumor-Fighting Nanobots Could Revolutionize Cancer Treatment

The system’s training involved large datasets from the Protein Data Bank and insights from Google’s previous AI research. By leveraging this wealth of data, AlphaProteo avoids the need for traditional, resource-intensive testing methods, saving both time and money.

One of the most significant achievements during AlphaProteo’s testing phase was the strength of the protein binders it produced. On average, these binders were ten times more effective than current designs. The research also included testing protein binders for various target molecules, including those related to diseases like COVID-19 and leukemia.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 23K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

At I/O 2026, Sundar Pichai Concedes AI Must Deliver Real Value

Gemini 3.5, a personal agent called Spark, agentic shopping, and Android XR eyewear are all aimed at making AI feel useful, not just impressive.

Published

on

at io 2026 sundar pichai concedes ai must deliver real value
Google

Google’s annual I/O developer conference (I/O 2026) has recently become a status update on the same question: can the company turn its AI spending into products people use every day? This year, chief executive Sundar Pichai described Google as being in a phase of hyper progress, while conceding this is the part of the cycle where people want to see real value in the products they use on a day-to-day basis.

The strategy on display was to push agents — AI systems that act on a user’s behalf — into nearly every Google product at once. Search now has an “intelligent search box” that returns generated explainer videos alongside links. Gmail, Docs, YouTube and Maps are gaining their own agent layers, including a Docs Live feature that turns spoken instructions into drafted text with citations.

Two new models, Gemini 3.5 and a cheaper Gemini 3.5 Flash, arrived the same day. Google says 900 million people now use Gemini, and that more than 50 billion images have been generated with it. The pricing tier names are likely to confuse buyers: a new AI Ultra plan launches at $100 a month, while the older Gemini AI Ultra drops from $250 to $200.

The flashier announcements were Gemini Omni, a video generator pitched as a more realistic answer to OpenAI’s discontinued Sora 2, and Gemini Spark, a personal agent that handles recurring tasks across a user’s Google account. A new universal shopping cart lets agents complete purchases across multiple retailers from inside Google itself, placing the company between the merchant and the buyer, and also owning the checkout.

Also Read: DJI Teases Dual-Camera Osmo Pocket 4P For 2026 Launch

Google also confirmed its Android XR eyewear, built with Samsung and frames from Warby Parker and Gentle Monster. Audio-only glasses ship this autumn; a display-equipped version, which would superimpose live translations into the wearer’s field of view, is still in development. Both sets translate, however only the display version shows you the result.

What Pichai did not resolve is the bargain underneath all this. An agent is only useful to the degree it knows your calendar, your inbox, your shopping history and your physical surroundings. Google has now confirmed that, in time, the same context may carry advertising.

Continue Reading

#Trending